Bon Gray

The Effect of Growth Hormone Administration on the Regulation of Mitochondrial Apoptosis in-Vivo

The purpose of this study was to determine whether recombinant human growth hormone (rhGH) would show any significant effects on the expression of apoptosis regulating proteins in peripheral blood mononuclear cells (PBMCs). Additionally, the potential for post-transcriptional regulation of gene expression by miRNA was assessed in two cellular compartments, the cytosol and the mitochondria. Ten male subjects were subcutaneously injected with either rhGH (1 mg) or saline (0.9%) for seven consecutive days in a double-blinded fashion. Blood sampling was undertaken prior to treatment administration and over a period of three weeks following treatment cessation. Bcl-2 and Bak gene and protein expression levels were measured in PBMCs, while attention was also directed to the expression of miR-181a and miR-125b, known translational inhibitors of Bcl-2 and Bak respectively. Results showed that rhGH significantly decreased Bak protein concentrations compared to placebo samples for up to 8 days post treatment. While cytosolic miRNA expression was not found to be significantly affected by rhGH, measurement of the expression of miR-125b in mitochondrial fractions showed a significant down-regulation eight days post-rhGH administration. These findings suggest that rhGH induces short-term anti-apoptotic effects which may be partially mediated through a novel pathway that alters the concentration of mitochondrially-associated miRNAs.

Validity and reliability of a novel salivary immunoassay for individual profiling in applied sports science.

The aim of this study was to examine the validity and reliability of a novel immunoassay, developed to assess salivary Immunoglobulin A (s-IgA). Validity and reliability of the Individual Profiling Lateral Flow Device (IPRO LFD) for s-IgA concentrations ([s-IgA]) was assessed in males (n = 12) and females (n =13) who were involved in recreational activities. Reliability of the IPRO LFD method was assessed by comparing [s-IgA] of two saliva samples collected concurrently, while validity was assessed by comparing with an enzyme-linked immunosorbent assay (ELISA) method. The IPRO LFD had a strong positive correlation (r = 0.93, p < 0.001), with no difference in [s-IgA] compared with the ELISA. The IPRO LFD was considered reliable (ICC r = 0.89, p < 0.001 and CV = 9.40 %) for measures of [s-IgA]. We concluded that the IPRO LFD method may be a substitute to the ELISA method for measurements of [s-IgA].

Physical demands and salivary immunoglobulin a responses of elite Australian rules football athletes to match play

PURPOSE To examine the response or pre- and postmatch salivary immunoglobulin A concentration ([s-IgA]) to Australian Football League (AFL) match play and investigate the acute and cumulative influence of player workload and postmatch [s-IgA] after repeated participation in AFL match play. METHODS Eleven elite AFL athletes (21.8±2.4 y, 186.9±7.9 cm, 87.4±7.5 kg) were monitored throughout 3 matches during the preseason that were separated by 7 d. Saliva samples were collected across each AFL match at 24 h and 1 h prematch and 1, 12, 36, and 60 h postmatch to determine [s-IgA]. Global positioning systems (GPS) with integrated triaxial accelerometers were used to determine total player workload during match play. Hypothesis testing was conducted for time-dependent changes in [s-IgA] and player load using a repeated-measures ANOVA. RESULTS Player load during match 3 (1266±124.6 AU) was significantly (P<.01) greater than in match 1 (1096±115.1 AU) and match 2 (1082±90.4 AU). Across match 3, [s-IgA] was significantly (P<.01) suppressed at 2 postmatch measures (12 and 36 h) compared with prematch measures (24 and 1 h), which coincided with significantly (P<.01) elevated player load. CONCLUSION The findings indicate that an increase in player load during AFL preseason match play resulted in compromised postmatch mucosal immunological function. Longitudinal assessment of AFL-match player load and mucosal immunological function across the first 60 h of recovery may augment monitoring and preparedness strategies for athletes.

The effect of recombinant human growth hormone and insulin-like growth factor-1 on the mitochondrial function and viability of peripheral blood mononuclear cells in vitro

This study investigated whether the putative physiological benefits induced by growth hormone (GH) and insulin-like growth factor-1 (IGF-1) are countered at supra-physiological concentrations because of an augmentation in the production of mitochondrial-derived free radicals with a subsequent increase in oxidative damage, compromising mitochondrial function. To test this hypothesis, peripheral blood mononuclear cells were incubated for 4 h with either recombinant human GH (rhGH) (range = 0.25-100 μg/L) or recombinant IGF-1 (rIGF-1) (range = 100-600 μg/L) and along with control samples were subsequently analyzed by flow cytometry for the determination of cellular viability, mitochondrial membrane potential (Δψm), mitochondrial superoxide (O2(-)) generation, and mitochondrial permeability transition pore (mtPTP) activity. Results showed levels of mitochondrial O2(-) generation to be significantly reduced compared with control samples (lymphocytes: 21.5 ± 1.6 AU; monocytes: 230.2 ± 9.8 AU) following rhGH treatment at both concentrations of 5 μg/L (13.5 ± 1.3 AU, P ≤ 0.05) and 10 μg/L (12.3 ± 1.5 AU, P ≤ 0.05) in lymphocytes and at 10 μg/L (153.4 ± 11.4 AU, P ≤ 0.05) in monocytes. However, no significant effect was found at either higher rhGH concentrations or following treatment with any concentration of rIGF-1. In addition, neither of the 2 hormones had any significant effect on Δψm, mtPTP activity, or on cellular viability. In conclusion, physiological concentrations of rhGH elicited a protective cellular effect through the reduction of oxidative free radicals within mitochondria. This antioxidant effect was diminished at supra-physiological concentrations but not to a level that would elicit disruption of mitochondrial function.

Seasonal Analysis of Mucosal Immunological Function and Physical Demands in Professional Australian Rules Footballers

PURPOSE To assess match-to-match variations in salivary immunoglobulin A concentration ([s-IgA]) measured at 36 h postmatch throughout an Australian Football League (AFL) premiership season and to assess the trends between 36-h-postmatch [s-IgA] and match-play exercise workloads throughout the same season. METHODS Eighteen elite male AFL athletes (24 ± 4.2 y, 187.0 ± 7.1 cm, 87.0 ± 7.6 kg) were monitored on a weekly basis to determine total match-play exercise workloads and 36-h-postmatch [s-IgA] throughout 16 consecutive matches in an AFL premiership season. Global positioning systems (GPS) with integrated triaxial accelerometers were used to measure exercise workloads (PlayerLoad) during each AFL match. A linear mixed-model analyses was conducted for time-dependent changes in [s-IgA] and player load. RESULTS A significant main effect was found for longitudinal postmatch [s-IgA] data (F16,240 = 3.78, P < .01) and PlayerLoad data (F16,66 = 1.98, P = .03). For all matches after and including match 7, a substantial suppression trend in [s-IgA] 36-h-postmatch values was found compared with preseason baseline [s-IgA]. CONCLUSION The current study provides novel data regarding longitudinal trends in 36-h-postmatch [s-IgA] for AFL athletes. Results demonstrate that weekly in-season AFL match-play exercise workloads may result in delayed mucosal immunological recovery beyond 36 h postmatch. The inclusion of individual athlete-monitoring strategies of [s-IgA] may be advantageous in the detection of compromised postmatch mucosal immunological function for AFL athletes.